F050 Itch
DESCRIPTION
Chronic pruritus, arising idiopathically or in association with cutaneous or systemic disease, may be incapacitating. This session is meant for the clinician who wants to understand how itch arises and how best to approach itch management in different clinical scenarios, including itch associated with allergic, systemic, neuropathic and psychiatric disorders. Expert itch clinicians and researchers will explain advances in our understanding of itch pathophysiology and will communicate their experience in the diagnosis and management of challenging itches, including prurigo nodularis, neuropathic and psychogenic itch. Novel and pipeline therapies and devices for the management of chronic itch will be discussed.
LEARNING OBJECTIVES
Categorize different types of chronic itch and utilize appropriate diagnostic tests in the evaluation of patients suffering form chronic pruritus.
Incorporate neuromodulators, immunomodulators and alternative therapies into the management of patients with chronic itch.
Describe new or pipeline agents to treat chronic itch.
SCHEDULE
9:00 AM
Introduction: Advances in Itch
Sarina Elmariah, MD, FAAD
9:10 AM
Updates in the Pathophysiology of Itch
Brian S Kim, MD, FAAD
9:35 AM
The Dermatologist’s Playbook for Chronic Itch
Shawn Kwatra, MD, FAAD
10:00 AM
Updates in Allergic Itch
Sarah Scott Chisolm, MD, FAAD
10:25 AM
Evolving pipeline for managment of itch
Gil Yosipovitch, MD
DIRECTOR
Sarina Elmariah, MD, FAAD
SPEAKERS
Sarah Scott Chisolm, MD, FAAD
Brian S Kim, MD, FAAD
Shawn Kwatra, MD, FAAD
Gil Yosipovitch, MD
DISCLOSURES
Sarah Scott Chisolm, MD, FAAD
AbbVie – Advisory Board(Honoraria); Cara Therapeutics – Other(No Compensation Received); Galderma USA – Advisory Board(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Kiniksa Pharmaceuticals, Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); Vifor Pharma – Advisory Board(Honoraria);
Sarina Elmariah, MD, FAAD
Eli Lilly – Other(Honoraria); Galderma Laboratories, LP – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);
Brian S Kim, MD, FAAD
23andMe – Consultant (1099 relationship)(Fees); AbbVie – Consultant(Fees); Almirall – Advisory Board(Honoraria); Amagma Therapeutics – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); AstraZeneca – Consultant (1099 relationship)(Fees); Bellus Health – Advisory Board(Honoraria); Blueprint Medicines – Board of Directors(Honoraria); BMS – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Clexio – Consultant (1099 relationship)(Fees); Daewoong Pharmaceuticals – Consultant(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Fees); Evommune, Inc. – Consultant (1099 relationship)(Fees); Galderma – Consultant (1099 relationship)(Fees); Genentech, Inc. – Consultant (1099 relationship)(Fees); GlaxoSmithKline – Consultant (1099 relationship)(Fees); Granular Therapeutics – Consultant(Fees); Guidepoint Global, LLC – Consultant(Fees); Incyte Corporation – Consultant(Fees); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Klirna – Founder(Stock); Klirna Biotech, Inc. – Founder(Stock); Leo Pharma Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Locus Biosciences – Stockholder(Stock); Micreos – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Honoraria); Nuogen Pharma – Founder(Stock); OM Pharma – Consultant(Fees); Pfizer Inc. – Consultant(Honoraria); Recens Medical – Consultant(Fees); Sanofi – Consultant(Fees); Sanofi Genzyme – Consultant(Fees); Sanofi/Regeneron – Advisory Board(Honoraria); Septerna – Consultant (1099 relationship)(Fees); Shaperon – Consultant(Fees); Teva Pharmaceuticals USA – Advisory Board(Fees); Trevi Therapeutics – Consultant(Fees); VeraDermics Inc. – Investigator(Fees);
Shawn Kwatra, MD, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); ASLAN Pharmaceuticals – Consultant(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); Castle Biosciences, Inc – Consultant(Honoraria); Celldex – Consultant(Honoraria); Galderma – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Gil Yosipovitch, MD
AbbVie – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); CeraVe – Advisory Board(Honoraria); Eli Lilly – Investigator(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); escient – Investigator(Fees), Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); GSK – Advisory Board(Honoraria); Kamari Pharma – Consultant(Fees); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Maruho Co., Ltd – Speaker/Faculty Education(Fees); Novartis – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Vifor Pharma – Consultant(Fees);